UniPixel, Inc. (NASDAQ: UNXL), a provider of Performance Engineered Films(TM) to the touch screen, flexible printed electronics and display markets, has achieved roll-to-roll pilot production of its InTouch Sensors(TM), a projected capacitive, multi-touch sensor film.UniPixel Inc (NASDAQ:UNXL) weekly performance is -11.45%. On last trading day company shares ended up $6.88. Analysts mean target price for the company is $9.50. UniPixel Inc (NASDAQ:UNXL) distance from 50-day simple moving average is 8.05%.
Valmont Industries, Inc. (VMI), maker of fabricated metal utility support structures and agricultural irrigation equipment, issued updated earnings guidance for the second quarter, and full fiscal year 2014, on Tuesday.Valmont Industries, Inc. (NYSE:VMI) shares fell -6.73% in last trading session and ended the day on $149.51. VMI Gross Margin is 28.30% and its return on assets is 9.30%. Valmont Industries, Inc. (NYSE:VMI) quarterly performance is 3.07%.
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, disclosed for the first time preclinical data for IMGN779. The data were presented at the 19(th) Congress of the European Hematology Association (EHA) meeting in Milan, Italy (abstract# P802). IMGN779 is a novel, CD33-targeting, DNA-alkylating ADC that is a potential treatment for acute myeloid leukemia (AML).ImmunoGen, Inc. (NASDAQ:IMGN) shares moved down -8.23% in last trading session and was closed at $12.04, while trading in range of $11.87-$12.78. ImmunoGen, Inc. (NASDAQ:IMGN) year to date performance is -17.93%.
Heron Therapeutics Inc (NASDAQ:HRTX) a specialty pharmaceutical company, announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to its existing shelf registration. All of the shares in the proposed offering are to be sold by Heron Therapeutics, Inc. Heron Therapeutics Inc (NASDAQ:HRTX) ended the last trading day at $11.64. Company weekly volatility is calculated as 6.11% and price to cash ratio as 4.84. Heron Therapeutics Inc (NASDAQ:HRTX) showed a negative weekly performance of -1.19%.
Alon USA Energy, Inc. (NYSE:ALJ) announced that Paul Eisman, President and Chief Executive Officer of Alon USA, will be participating in a refining panel discussion and holding one-on-one meetings on June 18, 2014 at the Tudor, Pickering, Holt & Company 10th Annual Summer Energy Conference in Houston, Texas. Alon USA Energy, Inc. (NYSE:ALJ) net profit margin is -0.50% and weekly performance is -7.56%. On last trading day company shares ended up $13.08. Analysts mean target price for the company is $19.35. Alon USA Energy, Inc. (NYSE:ALJ) distance from 50-day simple moving average is -12.88%.